Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peritonsillar Bupivacaine for Postoperative Emergence Delirium in Children
NCT06863714Completed
- Sponsor
- Şişli Hamidiye Etfal Training and Research Hospital
- Start
- Sep 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in emergence delirium (ED) and postoperative pain (2 arms), sponsored by Şişli Hamidiye Etfal Training and Research Hospital. Primary endpoint: Pediatric Emergence Delirium Scale at 60 months. Started Sep 2023; status: completed.
02
Drugs
bupivacaine
03
Conditions
emergence delirium (ED)postoperative pain
Beyond the preview
Go deeper on NCT06863714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06863714.